The pharmaceutical trade is partaking in a flurry of biotech offers and shifting scientific trials to China. It does so at a time when the U.S. is distancing from China.
Source link
March 10, 2026
131 Views
Is China Pharma’s New Cash Cow Or A Policy Risk?
The pharmaceutical trade is partaking in a flurry of biotech offers and shifting scientific trials to China. It does so at a time when the U.S. is distancing from China. Source link





:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)


:max_bytes(150000):strip_icc():format(jpeg)/Health-GettyImages-1484341547-2b72e64020e84487bb504cbe25299d4e.jpg?w=600&resize=600,400&ssl=1)
Recent Comments